A

  • Abbasi, Naghmeh The effect of body mass index on the morbidity and outcomes of COVID-19 in Iranian patients with multiple sclerosis [Volume 22, Issue 1, 2023, Pages 23-29]

  • Abna, Zohreh Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment [Volume 22, Issue 1, 2023, Pages 1-7]

  • Abna, Zohreh Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

  • Aboutorabi, Marzieh Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment [Volume 22, Issue 1, 2023, Pages 1-7]

  • Aboutorabi, Marzieh Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

  • Adibi, Iman Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment [Volume 22, Issue 1, 2023, Pages 1-7]

  • Adibi, Iman Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

  • Advani, Soroor Abnormalities of brain imaging in COVID-19 patients with neurological symptoms [Volume 22, Issue 3, 2023, Pages 162-169]

  • Afshari, Daryoush Horner syndrome: A new hypothesis for signaling pathway of enophthalmos sign [Volume 22, Issue 3, 2023, Pages 197-200]

  • Agarwal, Aastha A case of type II fucosidosis-diagnosed with neuroradiological and dysmorphological findings [Volume 22, Issue 4, 2023, Pages 265-267]

  • Ahadi, Reza Horner syndrome: A new hypothesis for signaling pathway of enophthalmos sign [Volume 22, Issue 3, 2023, Pages 197-200]

  • Alaei Tafti, Emad Stability monitoring of patients with myasthenia gravis using a mobile-based application [Volume 22, Issue 1, 2023, Pages 35-43]

  • Al-Amin, Ghadir Chronic pain among Lebanese individuals with spinal cord injury: Pain interference and impact on quality of life [Volume 22, Issue 4, 2023, Pages 238-248]

  • Alizadeh, Maryam On genotype-phenotype relationship of dystrophinopathies among Iranian population [Volume 22, Issue 4, 2023, Pages 231-237]

  • Alizadeh-Otaghvar, Hamid Reza Horner syndrome: A new hypothesis for signaling pathway of enophthalmos sign [Volume 22, Issue 3, 2023, Pages 197-200]

  • Almasi-Hashiani, Amir Waterpipe and cigarette smoking and drug and alcohol consumption, and the risk of primary progressive multiple sclerosis: A population-based case-control study [Volume 22, Issue 2, 2023, Pages 72-81]

  • AlSalti, Abdullah Prognosis and outcome in patients with chronic inflammatory demyelinating polyradiculoneuropathy in a tertiary center in Oman [Volume 22, Issue 3, 2023, Pages 144-148]

  • Amouzadeh, Effat The effect of atomoxetine on cognitive function in patients with multiple sclerosis [Volume 22, Issue 3, 2023, Pages 149-154]

  • Ansari, Behnaz On genotype-phenotype relationship of dystrophinopathies among Iranian population [Volume 22, Issue 4, 2023, Pages 231-237]

  • Ariaei, Armin Horner syndrome: A new hypothesis for signaling pathway of enophthalmos sign [Volume 22, Issue 3, 2023, Pages 197-200]

  • Asadi-Shekaari, Majid The role of transcranial direct current stimulation in diminishing the risk of pneumonia in patients with dysphagia: A double-blinded randomized clinical trial [Volume 22, Issue 3, 2023, Pages 155-161]

  • Asadollahzadeh, Elnaz Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment [Volume 22, Issue 1, 2023, Pages 1-7]

  • Asadollahzadeh, Elnaz Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

  • Asilsoy, Suna Evaluation of risk factors for recurrence of cutaneous adverse reactions due to anti-seizure medications in children: A retrospective study [Volume 22, Issue 4, 2023, Pages 210-216]

  • Askari, Mozhdeh Fear of re-infection, relapse, and anxiety during COVID-19 pandemic in patients with multiple sclerosis: A multi-center study [Volume 22, Issue 2, 2023, Pages 82-86]

  • Askari, Mozhdeh Social support and anxiety correlation with resilience in patients with multiple sclerosis during COVID-19 pandemic [Volume 22, Issue 4, 2023, Pages 217-220]

  • Ayoubi, Saeideh The prevalence of multiple sclerosis in Tehran, Iran, in 2020 [Volume 22, Issue 1, 2023, Pages 63-64]

  • Azari Jafari, Amirhossein The effect of induced hypertension in aneurysmal subarachnoid hemorrhage: A narrative review [Volume 22, Issue 3, 2023, Pages 188-196]

  • Azimi, Amirreza Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment [Volume 22, Issue 1, 2023, Pages 1-7]

  • Azimi, Amirreza The effect of body mass index on the morbidity and outcomes of COVID-19 in Iranian patients with multiple sclerosis [Volume 22, Issue 1, 2023, Pages 23-29]

  • Azimi, Amirreza Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

  • Azimi, Amirreza Evaluation of obsessive-compulsive disorder prevalence in Iranian patients with multiple sclerosis and its relationship with demographic characteristics [Volume 22, Issue 4, 2023, Pages 204-209]

B

  • Babaie, Siavash The association of serum carnitine levels with severity of fatigue in patients with multiple sclerosis: A pilot study [Volume 22, Issue 1, 2023, Pages 30-34]

  • Badshah, Mazhar Injudicious use of cranio-spinal imaging in Guillain-Barré syndrome in a low resource country [Volume 22, Issue 4, 2023, Pages 261-264]

  • Baghbanian, Seyed Mohammad Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment [Volume 22, Issue 1, 2023, Pages 1-7]

  • Baghbanian, Seyed Mohammad Factors associated with the number of months of delaying in multiple sclerosis diagnosis: Comparison of count regression models [Volume 22, Issue 2, 2023, Pages 65-71]

  • Baghbanian, Seyed Mohammad Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

  • Bagherieh, Sara Social support and anxiety correlation with resilience in patients with multiple sclerosis during COVID-19 pandemic [Volume 22, Issue 4, 2023, Pages 217-220]

  • Balabandian, Mohammad Plasma neurofilament light chain associated with impaired regional cerebral blood flow in healthy individuals [Volume 22, Issue 4, 2023, Pages 221-230]

  • Baratloo, Alireza A nomogram-based clinical tool for acute ischemic stroke screening in prehospital setting [Volume 22, Issue 1, 2023, Pages 58-62]

  • Basiri, Keivan On genotype-phenotype relationship of dystrophinopathies among Iranian population [Volume 22, Issue 4, 2023, Pages 231-237]

  • Bayati, Asghar Epidemiological parameters of multiple sclerosis in Chaharmahal and Bakhtiari Province, Iran [Volume 22, Issue 2, 2023, Pages 103-109]

  • Bitarafan, Sama The association of serum carnitine levels with severity of fatigue in patients with multiple sclerosis: A pilot study [Volume 22, Issue 1, 2023, Pages 30-34]

  • Borhani-Haghighi, Afshin The role of transcranial direct current stimulation in diminishing the risk of pneumonia in patients with dysphagia: A double-blinded randomized clinical trial [Volume 22, Issue 3, 2023, Pages 155-161]

  • Bozorgmehr, Rama Abnormalities of brain imaging in COVID-19 patients with neurological symptoms [Volume 22, Issue 3, 2023, Pages 162-169]

C

  • Chanabasanavar, Vijetha A case of type II fucosidosis-diagnosed with neuroradiological and dysmorphological findings [Volume 22, Issue 4, 2023, Pages 265-267]

  • Chase Johnson, William The effect of induced hypertension in aneurysmal subarachnoid hemorrhage: A narrative review [Volume 22, Issue 3, 2023, Pages 188-196]

  • Cheraghian, Bahman The effect of atomoxetine on cognitive function in patients with multiple sclerosis [Volume 22, Issue 3, 2023, Pages 149-154]

D

  • Darabi, Farideh Progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus, not receiving any immunosuppressant medication [Volume 22, Issue 2, 2023, Pages 137-139]

  • Dhirawani, Satvik A case of type II fucosidosis-diagnosed with neuroradiological and dysmorphological findings [Volume 22, Issue 4, 2023, Pages 265-267]

E

  • Ebadi, Zahra Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment [Volume 22, Issue 1, 2023, Pages 1-7]

  • Ebadi, Zahra Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

  • Ebrahimi, Narges The relationship between retinal layer thickness and cognition in patients with multiple sclerosis: A systematic review of current literature [Volume 22, Issue 1, 2023, Pages 50-57]

  • Elrayes, Mai Prognosis and outcome in patients with chronic inflammatory demyelinating polyradiculoneuropathy in a tertiary center in Oman [Volume 22, Issue 3, 2023, Pages 144-148]

  • Ertekin, Ayfer An assessment of Martin-Gruber anastomosis discrepancies between healthy individuals and patients with carpal tunnel syndrome in motor nerve conduction studies [Volume 22, Issue 3, 2023, Pages 179-187]

  • Eskandarieh, Sharareh The prevalence of multiple sclerosis in Tehran, Iran, in 2020 [Volume 22, Issue 1, 2023, Pages 63-64]

  • Eskandarieh, Sharareh Comparison of side effects of the dose-1 of AstraZeneca and Sinopharm vaccines in patients with multiple sclerosis in Kermanshah, Iran (2021) [Volume 22, Issue 1, 2023, Pages 8-15]

  • Eskandarieh, Sharareh Challenges of patients with multiple sclerosis in receiving health care services in Iran [Volume 22, Issue 1, 2023, Pages 16-22]

  • Eskandarieh, Sharareh Factors associated with the number of months of delaying in multiple sclerosis diagnosis: Comparison of count regression models [Volume 22, Issue 2, 2023, Pages 65-71]

  • Eskandarieh, Sharareh Waterpipe and cigarette smoking and drug and alcohol consumption, and the risk of primary progressive multiple sclerosis: A population-based case-control study [Volume 22, Issue 2, 2023, Pages 72-81]

  • Eskandarieh, Sharareh Epidemiological parameters of multiple sclerosis in Chaharmahal and Bakhtiari Province, Iran [Volume 22, Issue 2, 2023, Pages 103-109]

  • Etemadifar, Masoud Neuro-mucormycosis: Lessons from COVID-19-associated cases [Volume 22, Issue 4, 2023, Pages 255-260]

  • Etesam, Farnaz Evaluation of obsessive-compulsive disorder prevalence in Iranian patients with multiple sclerosis and its relationship with demographic characteristics [Volume 22, Issue 4, 2023, Pages 204-209]

F

  • Fakhri, Negin Comparison of side effects of the dose-1 of AstraZeneca and Sinopharm vaccines in patients with multiple sclerosis in Kermanshah, Iran (2021) [Volume 22, Issue 1, 2023, Pages 8-15]

  • Farpour, Hamid Reza The role of transcranial direct current stimulation in diminishing the risk of pneumonia in patients with dysphagia: A double-blinded randomized clinical trial [Volume 22, Issue 3, 2023, Pages 155-161]

  • Farpour, Sima The role of transcranial direct current stimulation in diminishing the risk of pneumonia in patients with dysphagia: A double-blinded randomized clinical trial [Volume 22, Issue 3, 2023, Pages 155-161]

  • Fielder, Tristan The effect of induced hypertension in aneurysmal subarachnoid hemorrhage: A narrative review [Volume 22, Issue 3, 2023, Pages 188-196]

  • Fneish, Sleiman Chronic pain among Lebanese individuals with spinal cord injury: Pain interference and impact on quality of life [Volume 22, Issue 4, 2023, Pages 238-248]

G

  • Ghaderi, Bardiya Progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus, not receiving any immunosuppressant medication [Volume 22, Issue 2, 2023, Pages 137-139]

  • Ghaderi-Yazdi, Bardiya Characteristic brain computed tomography of infective endocarditis after thrombolysis for ischemic stroke: A clinical note [Volume 22, Issue 3, 2023, Pages 201-202]

  • Ghadiri, Fereshteh Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment [Volume 22, Issue 1, 2023, Pages 1-7]

  • Ghadiri, Fereshteh Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review [Volume 22, Issue 2, 2023, Pages 110-114]

  • Ghadiri, Fereshteh Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

  • Ghaffari, Mehran Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment [Volume 22, Issue 1, 2023, Pages 1-7]

  • Ghaffari, Mehran Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

  • Ghajarzadeh, Mahsa The relationship between retinal layer thickness and cognition in patients with multiple sclerosis: A systematic review of current literature [Volume 22, Issue 1, 2023, Pages 50-57]

  • Ghajarzadeh, Mahsa Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review [Volume 22, Issue 2, 2023, Pages 110-114]

  • Ghajarzadeh, Mahsa Fear of re-infection, relapse, and anxiety during COVID-19 pandemic in patients with multiple sclerosis: A multi-center study [Volume 22, Issue 2, 2023, Pages 82-86]

  • Ghajarzadeh, Mahsa Adverse side effects of Glatiramer acetate and Interferon beta-1a in patients with multiple sclerosis: A systematic review of case reports [Volume 22, Issue 2, 2023, Pages 115-136]

  • Ghajarzadeh, Mahsa Social support and anxiety correlation with resilience in patients with multiple sclerosis during COVID-19 pandemic [Volume 22, Issue 4, 2023, Pages 217-220]

  • Ghalyanchi-Langroodi, Hamidreza Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment [Volume 22, Issue 1, 2023, Pages 1-7]

  • Ghalyanchi-Langroodi, Hamidreza Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

  • Ghasemi, Majid On genotype-phenotype relationship of dystrophinopathies among Iranian population [Volume 22, Issue 4, 2023, Pages 231-237]

  • Ghasemi, Pouria Neuro-mucormycosis: Lessons from COVID-19-associated cases [Volume 22, Issue 4, 2023, Pages 255-260]

  • Ghazisaeedi, Marjan Stability monitoring of patients with myasthenia gravis using a mobile-based application [Volume 22, Issue 1, 2023, Pages 35-43]

  • Ghiasian, Masoud Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment [Volume 22, Issue 1, 2023, Pages 1-7]

  • Ghiasian, Masoud Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

  • Golastani, Bahar Neuro-mucormycosis: Lessons from COVID-19-associated cases [Volume 22, Issue 4, 2023, Pages 255-260]

  • Goudarzi, Hooman Waterpipe and cigarette smoking and drug and alcohol consumption, and the risk of primary progressive multiple sclerosis: A population-based case-control study [Volume 22, Issue 2, 2023, Pages 72-81]

  • Günay, Çağatay Evaluation of risk factors for recurrence of cutaneous adverse reactions due to anti-seizure medications in children: A retrospective study [Volume 22, Issue 4, 2023, Pages 210-216]

H

  • Hamtaei-Ghashti, Sara Fear of re-infection, relapse, and anxiety during COVID-19 pandemic in patients with multiple sclerosis: A multi-center study [Volume 22, Issue 2, 2023, Pages 82-86]

  • Harirchian, Mohammad Hossein The association of serum carnitine levels with severity of fatigue in patients with multiple sclerosis: A pilot study [Volume 22, Issue 1, 2023, Pages 30-34]

  • Hasanzadeh, Taha Abnormalities of brain imaging in COVID-19 patients with neurological symptoms [Volume 22, Issue 3, 2023, Pages 162-169]

  • Hassan, Muhammad Injudicious use of cranio-spinal imaging in Guillain-Barré syndrome in a low resource country [Volume 22, Issue 4, 2023, Pages 261-264]

  • Hassani, Maryam Sadat The effect of induced hypertension in aneurysmal subarachnoid hemorrhage: A narrative review [Volume 22, Issue 3, 2023, Pages 188-196]

  • Heidari, Hora Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment [Volume 22, Issue 1, 2023, Pages 1-7]

  • Heidari, Hora Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

  • Hız Kurul, Semra Evaluation of risk factors for recurrence of cutaneous adverse reactions due to anti-seizure medications in children: A retrospective study [Volume 22, Issue 4, 2023, Pages 210-216]

  • Hooshyari, Zahra Abnormalities of brain imaging in COVID-19 patients with neurological symptoms [Volume 22, Issue 3, 2023, Pages 162-169]

  • Hosseini, Samaneh Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment [Volume 22, Issue 1, 2023, Pages 1-7]

  • Hosseini, Samaneh Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

  • Hosseini, Seyyed Mohammad Mahdi Abnormalities of brain imaging in COVID-19 patients with neurological symptoms [Volume 22, Issue 3, 2023, Pages 162-169]

  • Hosseinnataj, Abolfazl Factors associated with the number of months of delaying in multiple sclerosis diagnosis: Comparison of count regression models [Volume 22, Issue 2, 2023, Pages 65-71]

I

  • Iqbal, Mansoor Injudicious use of cranio-spinal imaging in Guillain-Barré syndrome in a low resource country [Volume 22, Issue 4, 2023, Pages 261-264]

J

  • Jahromi, Niloofar Challenges of patients with multiple sclerosis in receiving health care services in Iran [Volume 22, Issue 1, 2023, Pages 16-22]

  • Jalilian, Laya Abnormalities of brain imaging in COVID-19 patients with neurological symptoms [Volume 22, Issue 3, 2023, Pages 162-169]

K

  • Kamali, Hoda Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment [Volume 22, Issue 1, 2023, Pages 1-7]

  • Kamali, Hoda Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

  • Kangallı, Özge Evaluation of risk factors for recurrence of cutaneous adverse reactions due to anti-seizure medications in children: A retrospective study [Volume 22, Issue 4, 2023, Pages 210-216]

  • Kankam, Samuel Berchi Plasma neurofilament light chain associated with impaired regional cerebral blood flow in healthy individuals [Volume 22, Issue 4, 2023, Pages 221-230]

  • Kannaian, Subramaniyan Association analysis of serotonin transporter gene polymorphism among the South-Indian migraineurs [Volume 22, Issue 1, 2023, Pages 44-49]

  • Karimi, Somayeh A nomogram-based clinical tool for acute ischemic stroke screening in prehospital setting [Volume 22, Issue 1, 2023, Pages 58-62]

  • Kashipazha, Davood The effect of atomoxetine on cognitive function in patients with multiple sclerosis [Volume 22, Issue 3, 2023, Pages 149-154]

  • Kesavan, Pallavi Association analysis of serotonin transporter gene polymorphism among the South-Indian migraineurs [Volume 22, Issue 1, 2023, Pages 44-49]

  • Keshtkaran, Nika The association of serum carnitine levels with severity of fatigue in patients with multiple sclerosis: A pilot study [Volume 22, Issue 1, 2023, Pages 30-34]

  • Keyhani, Ali Evaluation of obsessive-compulsive disorder prevalence in Iranian patients with multiple sclerosis and its relationship with demographic characteristics [Volume 22, Issue 4, 2023, Pages 204-209]

  • Khaladkar, Sanjay M A case of type II fucosidosis-diagnosed with neuroradiological and dysmorphological findings [Volume 22, Issue 4, 2023, Pages 265-267]

  • Khameneh-Bagheri, Arash Abnormalities of brain imaging in COVID-19 patients with neurological symptoms [Volume 22, Issue 3, 2023, Pages 162-169]

  • Khamoushian, Kianoosh Comparison of side effects of the dose-1 of AstraZeneca and Sinopharm vaccines in patients with multiple sclerosis in Kermanshah, Iran (2021) [Volume 22, Issue 1, 2023, Pages 8-15]

  • Kheradmand, Mohsen Watershed infarction in COVID-19: The necessity of neuroimaging in patients with subtle neurological symptoms [Volume 22, Issue 3, 2023, Pages 170-178]

  • Kheradmand, Mohsen On genotype-phenotype relationship of dystrophinopathies among Iranian population [Volume 22, Issue 4, 2023, Pages 231-237]

  • Khorvash, Fariborz Watershed infarction in COVID-19: The necessity of neuroimaging in patients with subtle neurological symptoms [Volume 22, Issue 3, 2023, Pages 170-178]

  • Kouchaki, Ebrahim Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment [Volume 22, Issue 1, 2023, Pages 1-7]

  • Kouchaki, Ebrahim Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

M

  • Maleki, Nazanin Challenges of patients with multiple sclerosis in receiving health care services in Iran [Volume 22, Issue 1, 2023, Pages 16-22]

  • Markose, Shyma Stealthily growing large sinonasal lymphoma with intracranial extension [Volume 22, Issue 3, 2023, Pages 203-203]

  • Martami, Fahimeh Association of dietary patterns with migraine: A matched case-control study [Volume 22, Issue 2, 2023, Pages 87-95]

  • Mehrabi, Farzad Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment [Volume 22, Issue 1, 2023, Pages 1-7]

  • Mehrabi, Farzad Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

  • Mirmoeeni, Seyyedmohammadsadeq The effect of induced hypertension in aneurysmal subarachnoid hemorrhage: A narrative review [Volume 22, Issue 3, 2023, Pages 188-196]

  • Mirmosayyeb, Omid The relationship between retinal layer thickness and cognition in patients with multiple sclerosis: A systematic review of current literature [Volume 22, Issue 1, 2023, Pages 50-57]

  • Mirmosayyeb, Omid Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review [Volume 22, Issue 2, 2023, Pages 110-114]

  • Mirmosayyeb, Omid Social support and anxiety correlation with resilience in patients with multiple sclerosis during COVID-19 pandemic [Volume 22, Issue 4, 2023, Pages 217-220]

  • Mohammadi, Aida The relationship between retinal layer thickness and cognition in patients with multiple sclerosis: A systematic review of current literature [Volume 22, Issue 1, 2023, Pages 50-57]

  • Mohammadianinejad, Ehsan Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment [Volume 22, Issue 1, 2023, Pages 1-7]

  • Mohammadianinejad, Ehsan Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

  • Mohammadian Nejad, Ehsan The effect of atomoxetine on cognitive function in patients with multiple sclerosis [Volume 22, Issue 3, 2023, Pages 149-154]

  • Mohammadzadeh, Sevda Abnormalities of brain imaging in COVID-19 patients with neurological symptoms [Volume 22, Issue 3, 2023, Pages 162-169]

  • Mokari, Yousef Neuro-mucormycosis: Lessons from COVID-19-associated cases [Volume 22, Issue 4, 2023, Pages 255-260]

  • Moradi, Fatemeh Horner syndrome: A new hypothesis for signaling pathway of enophthalmos sign [Volume 22, Issue 3, 2023, Pages 197-200]

  • Mortazavi, Seyyed Hosein Waterpipe and cigarette smoking and drug and alcohol consumption, and the risk of primary progressive multiple sclerosis: A population-based case-control study [Volume 22, Issue 2, 2023, Pages 72-81]

  • Mousavi, Seyede Elham Comparison of side effects of the dose-1 of AstraZeneca and Sinopharm vaccines in patients with multiple sclerosis in Kermanshah, Iran (2021) [Volume 22, Issue 1, 2023, Pages 8-15]

  • Mousavinasab, Seyed Nouraddin Factors associated with the number of months of delaying in multiple sclerosis diagnosis: Comparison of count regression models [Volume 22, Issue 2, 2023, Pages 65-71]

N

  • Nabizadeh, Fardin Eculizumab in the treatment of neuromyelitis optica spectrum disorder [Volume 22, Issue 2, 2023, Pages 140-143]

  • Nabizadeh, Fardin Plasma neurofilament light chain associated with impaired regional cerebral blood flow in healthy individuals [Volume 22, Issue 4, 2023, Pages 221-230]

  • Naghizadeh, Mohammad Neuro-mucormycosis: Lessons from COVID-19-associated cases [Volume 22, Issue 4, 2023, Pages 255-260]

  • Nahayati, Mohammad Ali Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment [Volume 22, Issue 1, 2023, Pages 1-7]

  • Nahayati, Mohammad Ali Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

  • Naim, Ibrahim Chronic pain among Lebanese individuals with spinal cord injury: Pain interference and impact on quality of life [Volume 22, Issue 4, 2023, Pages 238-248]

  • Najafi, Mohammad Amin Watershed infarction in COVID-19: The necessity of neuroimaging in patients with subtle neurological symptoms [Volume 22, Issue 3, 2023, Pages 170-178]

  • Naser Moghadasi, Abdorreza Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment [Volume 22, Issue 1, 2023, Pages 1-7]

  • Naser Moghadasi, Abdorreza The relationship between retinal layer thickness and cognition in patients with multiple sclerosis: A systematic review of current literature [Volume 22, Issue 1, 2023, Pages 50-57]

  • Naser Moghadasi, Abdorreza The effect of body mass index on the morbidity and outcomes of COVID-19 in Iranian patients with multiple sclerosis [Volume 22, Issue 1, 2023, Pages 23-29]

  • Naser Moghadasi, Abdorreza Eculizumab in the treatment of neuromyelitis optica spectrum disorder [Volume 22, Issue 2, 2023, Pages 140-143]

  • Naser Moghadasi, Abdorreza Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review [Volume 22, Issue 2, 2023, Pages 110-114]

  • Naser Moghadasi, Abdorreza Fear of re-infection, relapse, and anxiety during COVID-19 pandemic in patients with multiple sclerosis: A multi-center study [Volume 22, Issue 2, 2023, Pages 82-86]

  • Naser Moghadasi, Abdorreza Waterpipe and cigarette smoking and drug and alcohol consumption, and the risk of primary progressive multiple sclerosis: A population-based case-control study [Volume 22, Issue 2, 2023, Pages 72-81]

  • Naser Moghadasi, Abdorreza Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

  • Naser Moghadasi, Abdorreza Evaluation of obsessive-compulsive disorder prevalence in Iranian patients with multiple sclerosis and its relationship with demographic characteristics [Volume 22, Issue 4, 2023, Pages 204-209]

  • Navardi, Samira Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment [Volume 22, Issue 1, 2023, Pages 1-7]

  • Navardi, Samira Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

  • Nazari, Shahrzad The effect of induced hypertension in aneurysmal subarachnoid hemorrhage: A narrative review [Volume 22, Issue 3, 2023, Pages 188-196]

  • Nikbakht, Roya Factors associated with the number of months of delaying in multiple sclerosis diagnosis: Comparison of count regression models [Volume 22, Issue 2, 2023, Pages 65-71]

  • Nofeli, Amir Hasan Abnormalities of brain imaging in COVID-19 patients with neurological symptoms [Volume 22, Issue 3, 2023, Pages 162-169]

O

  • Omrani, Mohammad Amin Epidemiological parameters of multiple sclerosis in Chaharmahal and Bakhtiari Province, Iran [Volume 22, Issue 2, 2023, Pages 103-109]

  • Orabi, Ali Chronic pain among Lebanese individuals with spinal cord injury: Pain interference and impact on quality of life [Volume 22, Issue 4, 2023, Pages 238-248]

P

  • Padmaja Satheesh, Aiswarya Association analysis of serotonin transporter gene polymorphism among the South-Indian migraineurs [Volume 22, Issue 1, 2023, Pages 44-49]

  • Paybast, Sepideh Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment [Volume 22, Issue 1, 2023, Pages 1-7]

  • Paybast, Sepideh Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

  • Pourhamzeh, Mahsa Plasma neurofilament light chain associated with impaired regional cerebral blood flow in healthy individuals [Volume 22, Issue 4, 2023, Pages 221-230]

  • Poursadeghfard, Maryam Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment [Volume 22, Issue 1, 2023, Pages 1-7]

  • Poursadeghfard, Maryam Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

Q

  • Qorbani, Mostafa Association of dietary patterns with migraine: A matched case-control study [Volume 22, Issue 2, 2023, Pages 87-95]

R

  • Rafiemanesh, Hosein A nomogram-based clinical tool for acute ischemic stroke screening in prehospital setting [Volume 22, Issue 1, 2023, Pages 58-62]

  • Ramezani, Mahtab A nomogram-based clinical tool for acute ischemic stroke screening in prehospital setting [Volume 22, Issue 1, 2023, Pages 58-62]

  • Raoofi, Amir Horner syndrome: A new hypothesis for signaling pathway of enophthalmos sign [Volume 22, Issue 3, 2023, Pages 197-200]

  • Rastkar, Mohsen Adverse side effects of Glatiramer acetate and Interferon beta-1a in patients with multiple sclerosis: A systematic review of case reports [Volume 22, Issue 2, 2023, Pages 115-136]

  • Razazian, Nazanin Comparison of side effects of the dose-1 of AstraZeneca and Sinopharm vaccines in patients with multiple sclerosis in Kermanshah, Iran (2021) [Volume 22, Issue 1, 2023, Pages 8-15]

  • Razeghi-Jahromi, Soodeh The effect of body mass index on the morbidity and outcomes of COVID-19 in Iranian patients with multiple sclerosis [Volume 22, Issue 1, 2023, Pages 23-29]

  • Rehman Syed Rasheed, Akram Husain Association analysis of serotonin transporter gene polymorphism among the South-Indian migraineurs [Volume 22, Issue 1, 2023, Pages 44-49]

  • Rezaei, Mansour Comparison of side effects of the dose-1 of AstraZeneca and Sinopharm vaccines in patients with multiple sclerosis in Kermanshah, Iran (2021) [Volume 22, Issue 1, 2023, Pages 8-15]

  • Rezaeimanesh, Nasim The effect of body mass index on the morbidity and outcomes of COVID-19 in Iranian patients with multiple sclerosis [Volume 22, Issue 1, 2023, Pages 23-29]

  • Rezaeimanesh, Nasim Evaluation of obsessive-compulsive disorder prevalence in Iranian patients with multiple sclerosis and its relationship with demographic characteristics [Volume 22, Issue 4, 2023, Pages 204-209]

  • Rostamihosseinkhani, Mahtab The role of transcranial direct current stimulation in diminishing the risk of pneumonia in patients with dysphagia: A double-blinded randomized clinical trial [Volume 22, Issue 3, 2023, Pages 155-161]

  • Rustamzadeh, Auob Horner syndrome: A new hypothesis for signaling pathway of enophthalmos sign [Volume 22, Issue 3, 2023, Pages 197-200]

S

  • Saadatnia, Mohammad Watershed infarction in COVID-19: The necessity of neuroimaging in patients with subtle neurological symptoms [Volume 22, Issue 3, 2023, Pages 170-178]

  • Sadek, Zahra Chronic pain among Lebanese individuals with spinal cord injury: Pain interference and impact on quality of life [Volume 22, Issue 4, 2023, Pages 238-248]

  • Sahraian, Mohammad Ali Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment [Volume 22, Issue 1, 2023, Pages 1-7]

  • Sahraian, Mohammad Ali The relationship between retinal layer thickness and cognition in patients with multiple sclerosis: A systematic review of current literature [Volume 22, Issue 1, 2023, Pages 50-57]

  • Sahraian, Mohammad Ali The prevalence of multiple sclerosis in Tehran, Iran, in 2020 [Volume 22, Issue 1, 2023, Pages 63-64]

  • Sahraian, Mohammad Ali Comparison of side effects of the dose-1 of AstraZeneca and Sinopharm vaccines in patients with multiple sclerosis in Kermanshah, Iran (2021) [Volume 22, Issue 1, 2023, Pages 8-15]

  • Sahraian, Mohammad Ali Challenges of patients with multiple sclerosis in receiving health care services in Iran [Volume 22, Issue 1, 2023, Pages 16-22]

  • Sahraian, Mohammad Ali The effect of body mass index on the morbidity and outcomes of COVID-19 in Iranian patients with multiple sclerosis [Volume 22, Issue 1, 2023, Pages 23-29]

  • Sahraian, Mohammad Ali Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review [Volume 22, Issue 2, 2023, Pages 110-114]

  • Sahraian, Mohammad Ali Factors associated with the number of months of delaying in multiple sclerosis diagnosis: Comparison of count regression models [Volume 22, Issue 2, 2023, Pages 65-71]

  • Sahraian, Mohammad Ali Waterpipe and cigarette smoking and drug and alcohol consumption, and the risk of primary progressive multiple sclerosis: A population-based case-control study [Volume 22, Issue 2, 2023, Pages 72-81]

  • Sahraian, Mohammad Ali Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

  • Sahraian, Mohammad Ali Epidemiological parameters of multiple sclerosis in Chaharmahal and Bakhtiari Province, Iran [Volume 22, Issue 2, 2023, Pages 103-109]

  • Sahraian, Mohammad Ali Adverse side effects of Glatiramer acetate and Interferon beta-1a in patients with multiple sclerosis: A systematic review of case reports [Volume 22, Issue 2, 2023, Pages 115-136]

  • Sahraian, Mohmmad Ali Fear of re-infection, relapse, and anxiety during COVID-19 pandemic in patients with multiple sclerosis: A multi-center study [Volume 22, Issue 2, 2023, Pages 82-86]

  • Salami, Zhaleh Association of dietary patterns with migraine: A matched case-control study [Volume 22, Issue 2, 2023, Pages 87-95]

  • Salari, Mehri Neuro-mucormycosis: Lessons from COVID-19-associated cases [Volume 22, Issue 4, 2023, Pages 255-260]

  • Saleh, Nour El-Hoda Chronic pain among Lebanese individuals with spinal cord injury: Pain interference and impact on quality of life [Volume 22, Issue 4, 2023, Pages 238-248]

  • Sarıkaya Uzan, Gamze Evaluation of risk factors for recurrence of cutaneous adverse reactions due to anti-seizure medications in children: A retrospective study [Volume 22, Issue 4, 2023, Pages 210-216]

  • Sarraf, Payam Stability monitoring of patients with myasthenia gravis using a mobile-based application [Volume 22, Issue 1, 2023, Pages 35-43]

  • Sedaghat, Nahad Neuro-mucormycosis: Lessons from COVID-19-associated cases [Volume 22, Issue 4, 2023, Pages 255-260]

  • Sedghi, Maryam On genotype-phenotype relationship of dystrophinopathies among Iranian population [Volume 22, Issue 4, 2023, Pages 231-237]

  • Seifi, Ali The effect of induced hypertension in aneurysmal subarachnoid hemorrhage: A narrative review [Volume 22, Issue 3, 2023, Pages 188-196]

  • Shabani, Mohammad Javad Evaluation of obsessive-compulsive disorder prevalence in Iranian patients with multiple sclerosis and its relationship with demographic characteristics [Volume 22, Issue 4, 2023, Pages 204-209]

  • Shabani, Ronak Horner syndrome: A new hypothesis for signaling pathway of enophthalmos sign [Volume 22, Issue 3, 2023, Pages 197-200]

  • Shab-Bidar, Sakineh Association of dietary patterns with migraine: A matched case-control study [Volume 22, Issue 2, 2023, Pages 87-95]

  • Shah, Muffaqam The effect of induced hypertension in aneurysmal subarachnoid hemorrhage: A narrative review [Volume 22, Issue 3, 2023, Pages 188-196]

  • Shah, Virna M. Stealthily growing large sinonasal lymphoma with intracranial extension [Volume 22, Issue 3, 2023, Pages 203-203]

  • Shahamati, Donya Association of dietary patterns with migraine: A matched case-control study [Volume 22, Issue 2, 2023, Pages 87-95]

  • Shahmohammadi, Sareh Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment [Volume 22, Issue 1, 2023, Pages 1-7]

  • Shahmohammadi, Sareh Iranian specialists’ approach to surgery in patients with multiple sclerosis [Volume 22, Issue 2, 2023, Pages 96-102]

  • Shamsaei, Gholamreza The effect of atomoxetine on cognitive function in patients with multiple sclerosis [Volume 22, Issue 3, 2023, Pages 149-154]

  • Sharifi, Meisam A nomogram-based clinical tool for acute ischemic stroke screening in prehospital setting [Volume 22, Issue 1, 2023, Pages 58-62]

  • Shaygannejad, Aysa Fear of re-infection, relapse, and anxiety during COVID-19 pandemic in patients with multiple sclerosis: A multi-center study [Volume 22, Issue 2, 2023, Pages 82-86]

  • Shaygannejad, Aysa Social support and anxiety correlation with resilience in patients with multiple sclerosis during COVID-19 pandemic [Volume 22, Issue 4, 2023, Pages 217-220]

  • Shaygannejad, Vahid Fear of re-infection, relapse, and anxiety during COVID-19 pandemic in patients with multiple sclerosis: A multi-center study [Volume 22, Issue 2, 2023, Pages 82-86]

  • Shaygannejad, Vahid Social support and anxiety correlation with resilience in patients with multiple sclerosis during COVID-19 pandemic [Volume 22, Issue 4, 2023, Pages 217-220]

  • Sikaroodi, Hajir Progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus, not receiving any immunosuppressant medication [Volume 22, Issue 2, 2023, Pages 137-139]

  • Sikaroodi, Hajir Characteristic brain computed tomography of infective endocarditis after thrombolysis for ischemic stroke: A clinical note [Volume 22, Issue 3, 2023, Pages 201-202]

  • Singh, Tejvir A case of type II fucosidosis-diagnosed with neuroradiological and dysmorphological findings [Volume 22, Issue 4, 2023, Pages 265-267]

  • Sistany-Allahabadi, Narges Challenges of patients with multiple sclerosis in receiving health care services in Iran [Volume 22, Issue 1, 2023, Pages 16-22]

T

  • Tierradentro-Garcia, Luis Octavio Watershed infarction in COVID-19: The necessity of neuroimaging in patients with subtle neurological symptoms [Volume 22, Issue 3, 2023, Pages 170-178]

  • Togha, Mansoureh Association of dietary patterns with migraine: A matched case-control study [Volume 22, Issue 2, 2023, Pages 87-95]

  • T. Ward, Richard Plasma neurofilament light chain associated with impaired regional cerebral blood flow in healthy individuals [Volume 22, Issue 4, 2023, Pages 221-230]

U

  • Uzuner, Nevin Evaluation of risk factors for recurrence of cutaneous adverse reactions due to anti-seizure medications in children: A retrospective study [Volume 22, Issue 4, 2023, Pages 210-216]

V

  • Vaheb, Saeed Fear of re-infection, relapse, and anxiety during COVID-19 pandemic in patients with multiple sclerosis: A multi-center study [Volume 22, Issue 2, 2023, Pages 82-86]

  • Vaheb, Saeed Social support and anxiety correlation with resilience in patients with multiple sclerosis during COVID-19 pandemic [Volume 22, Issue 4, 2023, Pages 217-220]

  • Vahidi, Mohammad Abnormalities of brain imaging in COVID-19 patients with neurological symptoms [Volume 22, Issue 3, 2023, Pages 162-169]

  • Varadharajan, Shriram Stealthily growing large sinonasal lymphoma with intracranial extension [Volume 22, Issue 3, 2023, Pages 203-203]

  • Vasudevan, Haritha Stealthily growing large sinonasal lymphoma with intracranial extension [Volume 22, Issue 3, 2023, Pages 203-203]

  • Veerabathiran, Ramakrishnan Association analysis of serotonin transporter gene polymorphism among the South-Indian migraineurs [Volume 22, Issue 1, 2023, Pages 44-49]

  • Veerappan, Umamaheshwari Association analysis of serotonin transporter gene polymorphism among the South-Indian migraineurs [Volume 22, Issue 1, 2023, Pages 44-49]

  • Vossough, Arastoo Watershed infarction in COVID-19: The necessity of neuroimaging in patients with subtle neurological symptoms [Volume 22, Issue 3, 2023, Pages 170-178]

Y

  • Yiş, Uluc Evaluation of risk factors for recurrence of cutaneous adverse reactions due to anti-seizure medications in children: A retrospective study [Volume 22, Issue 4, 2023, Pages 210-216]

Z

  • Zandifar, Alireza Watershed infarction in COVID-19: The necessity of neuroimaging in patients with subtle neurological symptoms [Volume 22, Issue 3, 2023, Pages 170-178]